drugset / Trial / NCT07516561
Efficacy and Safety of APSMNF in the Treatment of Male Androgenetic Alopecia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of APSMNF in the treatment of male androgenetic alopecia.
Timeline
- Start
- 2026-07-07
- Primary completion
- 2029-08-02
- Completion
- 2029-08-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APSMNF 1 | Unknown | — | — |
| Subject | APSMNF 2 | Unknown | — | — |
| Comparator | Eniagor® | Unknown | — | — |